← European Medicine Shortage Tracker · all medicines

Agalsidase beta shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Agalsidase beta has no active shortage reports in the tracked registers right now — recent history below.

Resolved  ATC — · also listed as: agalsidase beta · data refreshed 5 November 2026

Key facts

No register currently lists an active availability issue for Agalsidase beta. The most recent report in the tracked registers dates to 2013-11-04 and is closed; this page updates automatically if a new report is filed.

Resolved Listed in the EMA shortages catalogue — EU-level issue. EMA lists no available alternatives. EMA record ↗
WhereStatus & productsSinceExpected end Reason / alternativesSource
🇪🇺 EU-wide (EMA)Resolved
Fabrazyme (agalsidase beta)
2013-11-04—Fabry Disease
Alternatives: EMA lists no available alternatives.
register ↗

Full report history (1 register entry)

Every individual register entry for Agalsidase beta in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇪🇺 EUFabrazyme (agalsidase beta)Resolved2013-11-04—Fabry Disease

Frequently asked

Is Agalsidase beta currently in shortage in Europe?

No. As of 5 November 2026, none of the 10 tracked official registers list an active availability issue for Agalsidase beta.

Where does this Agalsidase beta availability data come from?

Directly from the official medicines-agency register that lists Agalsidase beta: EMA shortages catalogue (EU). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Agalsidase beta — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/agalsidase-beta/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Agalsidase beta availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/agalsidase-beta/">Agalsidase beta shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Agalsidase beta: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 5 November 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.